Hydrocortisone aceponate Ecuphar (previously Cortacare)
hydrocortisone aceponate
Table of contents
Overview
Hydrocortisone aceponate Ecuphar is a corticosteroid veterinary medicine used to treat inflamed and itchy skin conditions in dogs. It is also used to treat symptoms of itchy skin in dogs prone to allergies (atopic dermatitis).
Hydrocortisone aceponate Ecuphar contains the active substance hydrocortisone aceponate and is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance. The reference medicine for Hydrocortisone aceponate Ecuphar is Cortavance.
Authorisation details
Product details | |
---|---|
Name |
Hydrocortisone aceponate Ecuphar (previously Cortacare)
|
Agency product number |
EMEA/V/C/004689
|
Active substance |
hydrocortisone aceponate
|
International non-proprietary name (INN) or common name |
hydrocortisone aceponate
|
Species |
Dogs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QD07AC
|
Publication details | |
---|---|
Marketing-authorisation holder |
Ecuphar
|
Revision |
3
|
Date of issue of marketing authorisation valid throughout the European Union |
27/08/2018
|
Contact address |
Legeweg 157-i B-8020
Oostkamp 8020 Oostkamp Belgium |
Product information
17/12/2021 Hydrocortisone aceponate Ecuphar (previously Cortacare) - EMEA/V/C/004689 - IB/0005/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Corticosteroids, dermatological preparations
Therapeutic indication
For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.
For alleviation of clinical signs associated with atopic dermatitis in dogs.